col krauss - the danger of data
DESCRIPTION
TRANSCRIPT
Sickle Cell Disease in the Military What Do We Know?
COL Margot R. Krauss, MD, MPHAccession Medical Standards Analysis
and Research ActivityWalter Reed Army Institute of Research
AFEB 22 May 2002
Sickle Cell Disease
Group of diseases characterized by the production of Hb S resulting from the inheritance of a beta S gene and a gene for other abnormal hemoglobin which polymerizes with Hb SHb S molecules co-polymerize most effectively with other Hb S molecules and then in decreasing order Hb C, D, O, A, J, and F 70% Hb S and 30% Hb F not associated with clinical
disease
AFEB 22 May 2002
Sickle Cell Disease
Sickle cell anemia (Hb SS) Sickle-C disease (Hb SC)Sickle beta-thalassemia (S-thal) “o” type no normal beta globin is produced “+” some normal beta globin is produced
Other abnormal hemoglobins may not cause disease D (except D-Punjab), E, G, O
AFEB 22 May 2002
Sickle Cell Anemia
Homozygous sickle cell (Hb SS) 5-50% cells are permanently sickled Anemia moderate to severe
Average Hb 8.0g/dl (6-10) Retic count 10% (4-24%) Crisis not associated with increased anemia
Low MCV and high MCHC
Common sx: abdominal or bone pain Crisis generally 5-7 days
AFEB 22 May 2002
Sickle Cell Anemia
Newborn screening for sickle cell disease First started in NY 1975 Currently in > 40 states
Predisposition toward infection, pneumococcal pneumonia, staph or salmonella osteomyelitis PCN prophylaxis until age 5 for Hb SS or Hb S
betao thalassemia1989 - 85% survival rate at 20 yrs of age
AFEB 22 May 2002
Sickle Cell and Alpha Thalassemia
Co-inheritance of sickle cell anemia and alpha thalassemia is not unusual 30% black Americans have a single alpha gene
deletion Approximately 2% have deletion of 2 of the 4
alpha globin genes
Difficult to differentiate from Hb SS Relatively more Hb A2 Decreased mortality
AFEB 22 May 2002
Sickle C (Hb SC) disease
Anemia mild to moderate20% do not have anemia and are asymptomaticHemoglobin “crystals” noted regularly
Clinical disease much like SS - usually milderHb SC unusual aspectsAseptic necrosis of head of femur is common
(can occur in SS but not as frequently)Splenomegaly (palpable spleen in 65-80%)
AFEB 22 May 2002
Sickle Beta -Thalassemia Disease
Hb S betao thalassemia No beta globin synthesis Virtually indistinguishable from HbSS clinically and on
electrophoresis (HA2 >3%)
Hb S beta+ thalassemia Beta globin present but reduced Mild to moderate anemia Somewhat milder than Hb SC disease Hb S predominates Hb A 5-30%, HbA2 >3%
AFEB 22 May 2002
Estimates of Sickle Cell Disease
Sickle Cell Disease*African-American 1 / 375Native American 1 / 3,000
Hispanic 1 / 20,000Whites 1 / 60,000
*Agency for Health Care Policy and Research (AHCPR) 1993 Guidelines for Sickle Cell Disease: Screening, Diagnosis, Management, and Counseling
AFEB 22 May 2002
Sickle Cell Disease Among Black Americans
American Black Population**Sickle cell anemia 1/625 live births
Sickle-C disease 1/835 –1,100 live birthsS-Beta thalassemia 1/1,667 live births
Sickle-D disease 1/20,000 Sickle -persistent high F Hb 1/25,000
**Interpretation of Diagnostic Tests, 7th Ed Jacques Wallach 2000
AFEB 22 May 2002
Prevalence of Hemoglobin Disorders Among Black Americans
634 hemoglobin variantsAlpha thalassemia minor 57/1,000All homozygous S conditions 3.7/1,000Sickle cell anemia 1/1,000
* Wintrobe’s Clinical Hematology, 10th ed, 1999
AFEB 22 May 2002
Standard from DoDI 6130.4
The causes for rejection for appointment, enlistment, or induction are:
E1.2.1. Anemia. Any hereditary (282), acquired (283), aplastic (284), or unspecified (285) anemia that has not been permanently corrected with therapy.
AFEB 22 May 2002
SCD Found Among Early Loss (EPTS) Due to Anemia
ICD9: 282 (hereditary hemolytic anemia): Thalassemias (ICD9: 282.4)
Thalassemia minor Sickle cell thalassemia
Sickle cell anemia (ICD9: 282.6) Hb SS Hb SC
Other hemoglobinopathies (ICD9: 282.7) Sickle cell trait (ICD9: 282.5)
ICD9: 285 (other and unspecified anemia)
AFEB 22 May 2002
HbS Conditions Not Disqualifying Asymptomatic forms of hemoglobinopathiesHb SD (except D-Punjab)Hb SG
Approximately 20% of Hb SC diseaseSCT
AFEB 22 May 2002
Early Loss Due to Anemia,All Components, 1998-2000
219 EPTS with any mention of anemia119 (hereditary hemolytic anemia): (ICD9:282) 24% (23/94) of sickle disorders in the Army
98 (other and unspecified anemia): (ICD9:285) 50% (49/98) Army
1 each of aplastic anemia & acquired anemiaArmy represents 36% of all accessions43% (94/219) of all anemia related to SCD (ICD 9: 282.6)
AFEB 22 May 2002
MethodsDescriptive Enlisted accessions 1998 to 2000 Active duty only
Reserve and NG # not accurate for denominatorNot able to follow Reserve and NG after initial training
Confirmed SCD cases by EPTS record review - ICD9 282
Comparison of Services by EPTS (Existing Prior to Service <6mo) Hospitalizations (PASBA- original data)
Chart review Disability (service disability boards)
AFEB 22 May 2002
Laboratory Diagnosis SCD Sickle Cell Anemia No Hb A, Hb A2 normal Predominant Hb S Hb F in varying amounts
Hb S beta 0 thalassemia Virtually indistinguishable from Hb SS Hb A2 >3%
Hb S beta + thalassemia Hb A 5-30%, Hb A2 4-6% MCV<78
AFEB 22 May 2002
Other Diagnosis
Sickle cell trait - (Hb A> Hb S)Persistent Hemoglobin F
Approx Hb S 70% Hb F 30%Not associated with clinical disease
Hb SG - clinically silent
* Wintrobe’s Clinical Hematology, 10th ed, 1999
AFEB 22 May 2002
Army Policy on SCDNo screen for sickle disease or anemiaIdentified by clinical presentation
AFEB 22 May 2002
SCD in the Army, 1998-200040 EPTS coded hereditary anemia (ICD 9 282)17 other anemias 10 thalassemia minor7 other
18 AD records confirmed as SCDExcluded 5 Reserve and NG with SCD
AFEB 22 May 2002
SCD in the Army, 1998-200012/18 AD (67%) hospitalized for SCD6 PASBA record confirmed by EPTS record
5 in crisis (262.62)6 reported hospitalized by EPTS record only
Abdominal painBack pain, painful joints RhadomylosisAnemia
AFEB 22 May 2002
SCD Diagnosis on Army EPTS records
5 + Sickledex, type based on history/smearElectrophoresis- Full results usually not recorded on EPTS forms…best guess as to type below SS - 4SC - 6S-thalassemia - 7
7 with Hgb or Hct provided only 1 with a Hgb >12 (12.7 g/dl)
AFEB 22 May 2002
SCD in the Army, 1998-2000
No documented denial of disease16 (88%) gave history of SCT/SCD– not divulged on pre-screening at MEPS 13 gave a positive history of SCD/crisis 3 reported thinking they had SCT - had Hb SC
Safe to assume some are not identified No screening May be coded under 285 (other anemia) Some Hb S + conditions are asymptomatic
AFEB 22 May 2002
SCD Hospitalizations After Serving At Least 6 Months on AD: 1996-2000
Population # LOS Loss
Army 43 M11-Y18 22
Navy 7 M07-Y9 3
AF 6 Y3-Y18 1
Marines 6 Y01-Y09 3
Total 62 29
AFEB 22 May 2002
Hospitalization for SCD10 Army hospital records requested 4 locations: 2/3 confirmed (282.62) Hb SS/SC with crisis
Hb SC, Reported electrophoresis c/w Hb SS Death – electrophoresis Hb AS
1/1 confirmed (282.63) Hb SC Hb SC
2/5 confirmed (282.60) SCD, NOS Hb SC, S-thal Hb AS 2 sickledex + (no hemoglobin electrophoresis)
1/1 confirmed (282.69) Other hemoglobinopathies Hb SC
AFEB 22 May 2002
Hospitalizations
6/10 (60%) hospitalizations for SCD confirmed by chart review
Consistent with 60% loss after hospitalizations reported in the Army after 6 months on AD
AFEB 22 May 2002
Air Force Policy on SCT/SCD
Screens for SCT/SCDHemoglobin electrophoresis doneThose with SCT can leave the service under admin separationThose with SCD receive EPTS
AFEB 22 May 2002
SCD in the Air Force 1998 - 2000
18; 17 by screen / 1 symptomaticHemoglobin electrophoresis1 - SS11 - SC2 - S beta thal2 - Hb S plus another abnormal Hb 1 - SCT (symptomatic)1 - No lab provided
AFEB 22 May 2002
SCD in the Air Force1998 - 2000
50% (9/18) gave negative prior history at presentation All Hb SC or S-thalassemia One from West Africa had fought successfully in
several wars (in his country)5 gave history of SCD/crisis at presentation – not divulged on pre-screening at MEPS 1 Hb SS & 4 Hb SC 1-2 pain crisis/yr, hospitalization Mildest reported arthritic pains with running
AFEB 22 May 2002
Estimates of SCD Not Disclosed at MEPS
Expected: Used a high prevalence of SCD in an unscreened population than is probably real Based on reported incidence of disease at birth
Expect some may have died (Hb SS) from infection Reported incidence of disease by sub-types (Hb SS Hb SC
HbS-Thal) overestimate prevalence If incidence added together estimate is much higher than the
prevalence of all SCD among the black population
Observed: Used only confirmed SCD cases –if data was unclear they were excludedThis approach would overestimate the ability of the MEPS exam process to deny enter to those with SCD
AFEB 22 May 2002
SCD in the AF: Expected (no screening) vs Observed, 1998-2000
Black Pop Incid Exp Obs Diff?
18,328Hb SS 1/675 27 1 P<.001
Hb SC 1/8351/1100
2116
11 NS
Hb S -thal 1/1667 11 3 P<.001
Other SCD ? 2Total SCD 1/305 60 17 P<.001
AFEB 22 May 2002
Navy Policy on SCT/SCD
Screens SCD/SCTTwo-tier hemoglobin electrophoresisThose with SCD are dischargedThose with SCT remain on AD unless Hb S >45%EPTS reporting appears fairly complete
AFEB 22 May 2002
SCD in the Navy 1998 - 2000
69 EPTS records coded 282 8 thalassemias/ 2 Hb CC/ 1 ITP
18 coded SCT- 12 (67%) with documented SCD 6 SCT- 2 symptomatic
47 EPTS for sickle cell disease (SCD) confirmedAll but 1 case (Native Indian) in blacks 5 records not found- likely SCD Potential additional case
1 hospitalization due to SCD- lost to service
Probably 53+ cases of SCD in three year period
AFEB 22 May 2002
SCD in the Navy 1998-2000
EPTS records did not document whether the individual knew about his or her SCD prior to entry on to active duty
AFEB 22 May 2002
SCD in the Navy: Expected (no screening) vs Observed, 1998-2000
Incid Exp Obs
Hb SS 1/675 42 9 P<.0001Hb SC 1/835-
1/11003426
22 NS
Hb S -thal 1/1667 17 8 NSOther SCD ? 8TOTAL 1/ 304 93(H) 47(L) 51% (36-72%)
Black pop28272
AFEB 22 May 2002
SCD in the Navy: Estimate of SCD Not Detected at MEPS, 1998-2000
6Prob SCD71% (50%-100%)53751/375Total SCD
62% (43%-90%)47751/ 375Confirmed
Not detectedObsExpPrev28272Black pop
AFEB 22 May 2002
Estimate of SCD Not Detected at MEPS, 1998-2000
Population Army Navy AF Marine
Black 45,734 28,272 18,328 12,072
Prev=1/375
SCD (exp) 122 75 49 32
SCD EPTS 18 47 17 11
Approx % not identified at MEPS
15% 63% 35% 34%
AFEB 22 May 2002
Why does the Navy identify more SCD than the AF?
AF allows those with SCT to be administratively discharged (may actually have disease) Many incorrectly coded as SCT on Navy EPTS paperwork Generally those miscoded as SCT had S-thal If used only those originally coded as SCD
37-47% not identified at MEPS in the Navy (similar to % in AF)
AFEB 22 May 2002
Great Lakes Lab Report on Sickle Screening, 2001
Recruit screening tests: 50,993 Reserve screening tests: 6,084
Total screening tests: 57,077Positive sickle screens: 939 (1.6%) False positive 32/939 (3.4%)
Positive SCD 17/939 (1.8%) Approx 17 SCD/yr confirms what was found in
EPTS review H/H drawn on 2/17 with SCD
LCDR Brian T. McNamara, MSC, USNOIC Clinical Pathology Naval Hospital Great Lakes
AFEB 22 May 2002
Observation
Navy data provide most accurate numbers for SCD Initial coding not accurate, BUT Electrophoresis results generally fully described
allowing accurate determination of hemoglobinopathy
HOWEVER, no hx/o SCD or documented anemia Air Force & Army data provide history of SCD prior to service
AFEB 22 May 2002
SCD Impact to DoDDoD loses ~33 by EPTS/yr for SCD Navy ~17 Army ~6 Air Force ~ 6 Marine ~ 4
Maximum number of 4 additional losses per year following hospitalization for SCD after 6 months on AD (Army) Total ~8 hospitalizations occur every year due to SCD
(Army)2.8 SCD lost/10,000 accessions/yr
AFEB 22 May 2002
Cost Estimate of Testing for SCD at MEPS
Approx $1 million for testing alone if done at MEPS ~240,000 applicants receive physicals/yr $1.25 (GL) to $4 (CHPPM)/SCT screen $300K to $960K to identify 3,840 +SCT
Assume 1.6% +SCT (Navy’s prevalence) Assume $14/hemoglobin electrophoresis for +SCT $53,760 to identify 69 with SCD
Approximate cost: $6K to $14K per SCD identifiedOther costs not considered Counseling for +SCT Loss of those +SCT who might misunderstand the significance of the
test
AFEB 22 May 2002
Confusion Is Common Between SCT and SCD
Incorrect EPTS code: 67% SCT reported on EPTS (Navy) actually was due to SCDIncorrect history: At least three recruits in the Army thought they had SCT when they had disease (Hb SC)Incorrect Hospitalization discharge diagnosis code: 2/10 with hospitalization discharge diagnosis for SCD (Army) had SCT 2 additional cases with SCT (without hemoglobin electrophoresis)
AFEB 22 May 2002
Not All SCD is Clinically Significant
50% of those identified with screening program in the AF gave no history of SCDOver 80% in Army gave a positive history
Some with SC disease (Army) on AD for up to 18 yearsAt least two with apparent SCD (by hospitalization discharge diagnosis Army) found fit for duty at PEB
AFEB 22 May 2002
ConclusionsSCD is a rare disorder in the military currently identified by screening in the AF, Navy & Marines at basic training and usually by clinical presentation in the ArmyCurrent screening at MEPS does not identify at least 50% of those with SCD, perhaps moreScreening specifically for SCT/SCD at MEPS would be expensive and possibly falsely discourage applicants with SCT from entering ADUncorrectable anemia is the true disqualifying condition
AFEB 22 May 2002
Questions ?
AFEB 22 May 2002
Results Depend on Type of Electrophoresis
Navy (GL) uses Alkaline/Acid Electrophoresis Beckman Coulter Paragon Kits Excellent ability to differentiate variant Hb
Unknown what type of electrophoresis used in the AF or Army Some systems Hb A and F can not be reliably
separated Some electrophoresis do not detect Hb A 2
AFEB 22 May 2002
Estimate of SCT Among Black Recruits
3.4%3.5%6%1.5%Approx % SCD/SCT
11174718SCD EPTS
3224897541212SCT (exp)
Prev=8%
40246,1099,42415,247Black
MarineAFNavyArmyPopulation
AFEB 22 May 2002
Great Lakes Lab Report on Sickle Screening, 2001
Rate for est black pop 17/9424 (.18%)Obs/Exp =17/25 67% “missed” at MEPS95% CI includes 100% Possible that no one self-defers for SCD More likely some with Hb SS do self-defer (p<.001) SC and S-thal coming in at expected rate
Probably > half of these are unaware of SCD Based on review of AF EPTS records Might be able to stay on AD